D. MacKinnon-Cameron

发表

Safety and Immunogenicity of 2 Mixed Primary Infant Immunization Schedules of Pentavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliomyelitis, and Haemophilus influenzae Type b Vaccines at 2, 4, and 6 Months of Age: A Randomized Controlled Trial

J. Langley, S. Halperin, S. Mcneil, 2012, The Pediatric infectious disease journal.

The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers

J. Langley, S. Halperin, D. Macdougall, 2015, BMJ Open.

Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014.

S. Trottier, M. Loeb, B. Light, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know

J. Langley, S. Halperin, D. Macdougall, 2015, Human vaccines & immunotherapeutics.

A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response

O. Vanderkooi, J. Langley, A. Gruslin, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada

J. Langley, S. Halperin, J. Bettinger, 2020, Emerging infectious diseases.

Routine immunization of adults by pharmacists: Attitudes and beliefs of the Canadian public and health care providers

J. Langley, S. Halperin, J. Isenor, 2016, Human vaccines & immunotherapeutics.

Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial

W. J. Ramsey, T. Monath, J. Alimonti, 2017, Canadian Medical Association Journal.

Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada

S. Trottier, M. Loeb, A. Chit, 2017, BMC Infectious Diseases.

Pertussis immunization in paediatric healthcare workers: knowledge, attitudes, beliefs, and behaviour.

S. Halperin, K. Top, D. MacKinnon-Cameron, 2010, Vaccine.

Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay.

S. Trottier, M. Loeb, W. Demczuk, 2022, Vaccine.

Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015

S. Trottier, M. Loeb, W. Demczuk, 2020, BMJ Open Respiratory Research.

Age-stratifiedburdenofpneumococcal communityacquiredpneumoniain hospitalisedCanadianadultsfrom2010 to2015

S. Trottier, M. Loeb, W. Demczuk, 2020 .

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).

S. Trottier, M. Loeb, W. Demczuk, 2019, Vaccine.

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.

S. Trottier, M. Loeb, I. Martin, 2017, Vaccine.

Impact of respiratory viral infections on mortality and critical illness among hospitalized patients with chronic obstructive pulmonary disease

A. Forster, M. Andrew, S. Aaron, 2022, Influenza and other respiratory viruses.

Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.

J. Langley, S. Halperin, D. Macdougall, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of a 30-valent M protein-based group a streptococcal vaccine in healthy adult volunteers: A randomized, controlled phase I study.

J. Langley, S. Halperin, S. Mcneil, 2019, Vaccine.

Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial

J. Langley, S. Halperin, D. Macdougall, 2016, Human vaccines & immunotherapeutics.

High-Level Immunogenicity Is Achieved Vaccine With Adjuvanted Pandemic H1N12009 and Improved With Booster Dosing in a Randomized Trial of HIV-Infected Adults

S. Walmsley, S. Halperin, C. Cooper, 2012, HIV Clinical Trials.

Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).

S. Trottier, M. Loeb, A. Chit, 2018, Vaccine.

Older Age and Frailty are Associated with Higher Mortality but Lower ICU Admission with COVID-19

S. Trottier, M. Loeb, L. Valiquette, 2022, Canadian geriatrics journal : CGJ.

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

J. Langley, B. Schepens, X. Saelens, 2018, The Journal of infectious diseases.

Healthcare provider awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers

S. Halperin, J. Isenor, D. Halperin, 2022, Human vaccines & immunotherapeutics.

Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine

J. Langley, S. Halperin, B. Ward, 2013, Human vaccines & immunotherapeutics.

Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

S. Madhi, P. Koul, M. Tortajada-Girbés, 2019, BMC Public Health.

Interim estimates of 2014/15 influenza vaccine effectiveness in preventing laboratory-confirmed influenza-related hospitalisation from the Serious Outcomes Surveillance Network of the Canadian Immunization Research Network, January 2015.

M. Loeb, V. Shinde, M. Andrew, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.

S. Trottier, M. Loeb, V. Shinde, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People

S. Trottier, M. Loeb, A. Chit, 2017, The Journal of infectious diseases.

A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18–50 Years of Age

J. Langley, J. Cailhier, P. Savard, 2020, Vaccines.

Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia

A. Dibernardo, S. Mcneil, J. LeBlanc, 2020, Journal of Clinical Microbiology.

Hepatitis A and travel amongst Nova Scotia postsecondary students: evidence for a targeted vs. universal immunization strategy.

J. Langley, S. Halperin, S. Mcneil, 2008, Vaccine.

Study of Cerebrospinal Fluid Shunt–Associated Infections in the First Year Following Placement, by the Canadian Nosocomial Infection Surveillance Program

J. Langley, D. Gravel, A. Matlow, 2009, Infection Control & Hospital Epidemiology.

Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program.

J. Langley, S. Halperin, D. Macdougall, 2016, Vaccine.

Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial

J. Langley, P. Cahn, Wei Chen, 2021, The Lancet.

Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study.

O. Vanderkooi, S. Kuhn, J. Langley, 2012, Vaccine.

Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults.

J. Langley, S. Halperin, W. Heyward, 2012, Vaccine.

Maintaining the momentum: Key factors influencing acceptance of influenza vaccination among pregnant women following the H1N1 pandemic

S. Halperin, S. Mcneil, D. MacKinnon-Cameron, 2014, Human vaccines & immunotherapeutics.

Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season

S. Trottier, M. Loeb, B. Light, 2016 .

Influenza Vaccine Effectiveness in the Prevention of Influenza-Related Hospitalization in Canadian Adults Over the 2011/12 Through 2013/14 Season: A Pooled Analysis From the Serious Outcomes Surveillance (SOS) Network of the Canadian Influenza Research Network (CIRN)

S. Trottier, M. Loeb, B. Light, 2016 .

Knowledge, attitudes, beliefs, and behaviors of university students, faculty, and staff during a meningococcal serogroup B outbreak vaccination program.

J. Langley, S. Halperin, K. Top, 2017, Vaccine.

Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.

J. Langley, S. Halperin, K. Top, 2016, Vaccine.

Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network

S. Trottier, R. Goeree, M. Loeb, 2018, Influenza and other respiratory viruses.

High-Level Immunogenicity Is Achieved Vaccine With Adjuvanted Pandemic H1N12009 and Improved With Booster Dosing in a Randomized Trial of HIV-Infected Adults

S. Walmsley, S. Halperin, C. Cooper, 2012, HIV clinical trials.

Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What the Canadian public knows and wants to know.

J. Langley, S. Halperin, D. Macdougall, 2015, Vaccine.

Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD

S. Trottier, M. Loeb, A. Chit, 2019, Chest.

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults

S. Trottier, M. Loeb, A. Chit, 2019, Journal of medical microbiology.

Leveraging Influenza Virus Surveillance From 2012 to 2015 to Characterize the Burden of Respiratory Syncytial Virus Disease in Canadian Adults ≥50 Years of Age Hospitalized With Acute Respiratory Illness

S. Trottier, M. Loeb, J. Langley, 2023, Open forum infectious diseases.

Public awareness, attitudes, beliefs, and behaviors regarding the role of pharmacists as immunizers

S. Halperin, J. Isenor, D. Halperin, 2021, Human vaccines & immunotherapeutics.